N-(2-chlorophenyl)propynamide | 27703-41-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(2-chlorophenyl)propynamide
• 英文别名: N-(2-chlorophenyl)propiolamide；N-(2-chlorophenyl)-2-propynamide；N-(2-chlorophenyl)prop-2-ynamide
• CAS: 27703-41-9
• 化学式: C₉H₆ClNO
• 分子量: 179.606
• InChiKey: VVATUBNVIWLOLB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  N-(2-chlorophenyl)propynamide 、 4β-azido-4-deoxypodophyllotoxin 在 copper(II) sulfate 、 维生素 C 作用下， 以 水 、 叔丁醇 为溶剂， 反应 2.0h， 以60%的产率得到4β-[4-(2-chlorophenylaminocarbonyl)-1,2,3-triazole]-podophyllotoxin
  参考文献：
  名称：

  Synthesis of 4β-triazole-podophyllotoxin derivatives by azide–alkyne cycloaddition and biological evaluation as potential antitumor agents

  摘要：

  A representative synthetic process of derivatizing the natural product podophyllotoxin utilizing the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is described including molecular design, reaction optimization and X-ray structure confirmation. Evaluation of cytotoxicity against human cancer cell lines (Hela, K562 and K562/A02) using MTT assay proves that these triazole derivatives have good antitumor activities. High activities toward the drug resistant K562/A02 cell line reveal promising future for these derivatives. The rarely prepared 1,5-disubstituted triazole isomers, which would be omitted by the "click chemistry", were found to have superior cytotoxicities to that of the 1,4-disubstituted isomers. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.07.024
• 作为产物：
  描述：

  邻氯苯胺 、 丙炔酸 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以60 %的产率得到N-(2-chlorophenyl)propynamide
  参考文献：
  名称：

  发现 N-苯基丙醇酰胺作为新型琥珀酸脱氢酶抑制剂支架，对植物病原真菌具有广谱抗真菌活性

  摘要：

  基于琥珀酸脱氢酶抑制剂 (SDHI) 和靶向共价抑制剂的结构特征，设计了一系列含有迈克尔受体部分的N-苯基丙酰胺，以寻找新的抗真菌化合物。十九种化合物在体外对九种植物病原真菌显示出有效的抑制活性。化合物9和13对大多数真菌表现出比标准药物嘧菌酯更高的活性。化合物13可完全抑制Physalospora piricola在 200 μg/mL 的浓度下感染苹果超过 7 天，并且在≤100 μg/mL 的浓度下对植物的种子萌发和幼苗生长表现出高度安全性。作用机制表明，13是一种SDH抑制剂，中值抑制浓度IC 50为0.55 μg/mL，与阳性药物啶酰菌胺相当。分子对接研究表明，13可以通过氢键与SDH的泛醌结合区很好地结合，并发生π-烷基相互作用和π-阳离子相互作用。在细胞水平上，1作为母体化合物可以破坏P. piricola的菌丝结构并部分溶解细胞壁和/或细胞膜。构效关系分析表明，乙炔基应该是

  DOI：

  10.1021/acs.jafc.2c07712

文献信息

• Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitors
  作者：Lixin Qiao、Sungwoon Choi、April Case、Thomas G. Gainer、Kathleen Seyb、Marcie A. Glicksman、Donald C. Lo、Ross L. Stein、Gregory D. Cuny

  DOI：10.1016/j.bmcl.2009.09.010

  日期：2009.11

  enhanced mouse liver microsome stability. The structure–activity relationship for EphB3 inhibition of both heterocyclic series was similar. Kinase inhibitory activity was also demonstrated for representative analogs in cell culture. An analog (32, LDN-211904) was also profiled for inhibitory activity against a panel of 288 kinases and found to be quite selective for tyrosine kinases. Overall, these studies

  吡唑并[1,5- a ]吡啶的 2-氯苯胺衍生物的构效关系研究表明，通过保留 2-氯苯胺并向 5吡唑并[1,5- a ]吡啶的-位。此外，用咪唑并[1,2- a ]吡啶替代吡唑并[1,5- a ]吡啶具有良好的耐受性，并导致小鼠肝微粒体稳定性增强。EphB3 抑制两种杂环系列的构效关系相似。细胞培养中的代表性类似物也证明了激酶抑制活性。一个模拟 ( 32, LDN-211904) 还分析了对一组 288 种激酶的抑制活性，发现对酪氨酸激酶具有很高的选择性。总体而言，这些研究为检查 EphB3 受体的体外、细胞和潜在的体内激酶依赖性功能提供了有用的分子探针。
• Inhibiting EPH B-3 Kinase
  申请人：Qiao Lixin

  公开号：US20120238597A1

  公开（公告）日：2012-09-20

  EphB3 kinase inhibitor compounds, including certain pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine compounds, inhibit EphB3 kinase. The EphB3 kinase inhibitor compounds can have greater potency for the inhibition of EphB3 kinase than general kinase inhibitors. Pharmaceutical compositions, such as neuroprotective agents, comprising the EphB3 kinase inhibitor compounds are also provided. The EphB3 kinase inhibitor compounds and pharmaceutical compositions are useful, for example, to provide neuroprotection and/or repair of neuronal tissue damaged during an ischemic event, such as a stroke.
• US8927545B2
  申请人：——

  公开号：US8927545B2

  公开（公告）日：2015-01-06
• [EN] INHIBITING EPH B-3 KINASE<br/>[FR] INHIBITION DE L'ENZYME EPHB3 KINASE
  申请人：BRIGHAM & WOMENS HOSPITAL

  公开号：WO2010117787A2

  公开（公告）日：2010-10-14

  EphB3 kinase inhibitor compounds, including certain pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine compounds, inhibit EphB3 kinase. The EphB3 kinase inhibitor compounds can have greater potency for the inhibition of EphB3 kinase than general kinase inhibitors. Pharmaceutical compositions, such as neuroprotective agents, comprising the EphB3 kinase inhibitor compounds are also provided. The EphB3 kinase inhibitor compounds and pharmaceutical compositions are useful, for example, to provide neuroprotection and/or repair of neuronal tissue damaged during an ischemic event, such as a stroke.
• Synthesis of 4β-triazole-podophyllotoxin derivatives by azide–alkyne cycloaddition and biological evaluation as potential antitumor agents
  作者：Hong Chen、Song Zuo、Xiaochen Wang、Xiaowei Tang、Ming Zhao、Yanling Lu、Liting Chen、Jing Liu、Yongfeng Liu、Dailin Liu、Shi Zhang、Tan Li

  DOI：10.1016/j.ejmech.2011.07.024

  日期：2011.9

  A representative synthetic process of derivatizing the natural product podophyllotoxin utilizing the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is described including molecular design, reaction optimization and X-ray structure confirmation. Evaluation of cytotoxicity against human cancer cell lines (Hela, K562 and K562/A02) using MTT assay proves that these triazole derivatives have good antitumor activities. High activities toward the drug resistant K562/A02 cell line reveal promising future for these derivatives. The rarely prepared 1,5-disubstituted triazole isomers, which would be omitted by the "click chemistry", were found to have superior cytotoxicities to that of the 1,4-disubstituted isomers. (C) 2011 Elsevier Masson SAS. All rights reserved.